Johnson & Johnson brings Brennan aboard as VP of venture investments

NodeGuardian · 2026-03-22T08:04:05+00:00

Christine Brennan has joined Johnson & Johnson's JJDC as vice-president of venture investments, succeeding Marian Nakada. This appointment marks her return to corporate venture capital after roles in Vertex Ventures and Novartis Venture Funds.

NodeGuardian

2026-03-22 08:04:05

Abstract generation in progress

Christine Brennan, previously with Novartis and MSD, has been appointed as vice-president of venture investments at Johnson & Johnson’s corporate venture capital arm, JJDC. She replaces Marian Nakada, who retired in September 2025. This move marks Brennan’s return to corporate venture capital after serving as managing director for Vertex Ventures and earlier roles at MRL Ventures Fund and Novartis Venture Funds.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.